Intracerebral injection of AMPA causes axonal damage in vivo

Brain Research

Volumn 991, Issue 1-2, 2003, Pages 104-112

  Fowler, Jill H ^a   McCracken, Eileen ^a   Dewar, Deborah ^a   McCulloch, James ^b  

^a UNIVERSITY OF GLASGOW   (United Kingdom)

^b UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

AMPA; Axonal damage; Cytoskeleton; SPD 502; White matter damage

Indexed keywords

2 [5 (4 DIMETHYLSULFAMOYLPHENYL) 6,7,8,9 TETRAHYDRO 8 METHYL 2 OXO 1H PYRROLO[3,2 H]ISOQUINOLIN 3 YLIMINOXY] 4 HYDROXYBUTYRIC ACID; ALPHA AMINO 3 HYDROXY 5 METHYL 4 ISOXAZOLEPROPIONIC ACID; AMPA RECEPTOR; AMPA RECEPTOR ANTAGONIST; MICROTUBULE ASSOCIATED PROTEIN 5; MYELIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CYTOSKELETON; CYTOTOXICITY; EXPERIMENTAL MODEL; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; IN VIVO STUDY; MALE; MICROTUBULE; NERVE FIBER; NERVE INJURY; NEUROFILAMENT; NONHUMAN; PERIKARYON; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RAT; RECEPTOR BLOCKING; WHITE MATTER;

EID: 0142027116     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brainres.2003.08.004     Document Type: Article

References (51)

1. Agrawal S.K., Fehlings M.G. Role of NMDA and non-NMDA glutamate receptors in traumatic spinal cord injury. J. Neurosci. 17:1997;1055-1063.
2. Bjartmar C., Trapp B.D. Axonal and neuronal degeneration in multiple sclerosis: mechanisms and functional consequences. Curr. Opin. Neurol. 14:2001;271-278.
3. Bjartmar C., Xinghua Y., Trapp B.D. Axonal pathology in myelin disorders. J. Neurocytol. 28:1999;335-383.
4. Brand-Schieber E., Werner P. AMPA/kainate receptors in mouse spinal cord cell-specific display of receptor subunits by oligodendrocytes and astrocytes at the nodes of ranvier. Glia. 42:2003;12-24.
5. Dewar D., Dawson D.A. Changes of cytoskeletal protein immunostaining in myelinated fibre tracts after focal cerebral ischaemia in the rat. Acta Neuropathol. 93:1997;71-77.
6. Dietrich W.D., Kraydieh S., Prado R., Stagliano N.E. White matter alterations following thromboemblolic stroke: a β-amyloid precursor protein immunocytochemical study in rats. Acta Neuropathol. 95:1998;524-531.
7. Frahm H.D., Stephan H., Stephan M. Comparison of brain structure volumes in Insectivora and Primates: I. Neocortex. J. Hirnforsch. 23:1982;375-389.
8. Gahm C., Holmin S., Mathiesen T. Nitric oxide synthase expression after human brain contusion. Neurosurgery. 50:2002;1319-1326.
9. Gallo V., Ghiani C.A. Glutamate receptors in glia: new cells, new inputs and new functions. TIPS. 21:2000;252-258.
10. Garbern J.Y., Yool D.A., Moore G.J., Wilds I.B., Faulk M.W., Klugmann M., Nave K.-A., Sistermans E.A., van der Knaap M.S., Bird T.D., Shy M.E., Kamholz J.A., Griffiths I.R. Patients lacking the major CNS myelin protein, proteolipid protein 1, develop length-dependent axonal degeneration in the absence of demyelination and inflammation. Brain. 125:2002;551-561.
11. Garthwaite G., Goodwin D.A., Batchelor A.M., Leeming K., Garthwaite J. Nitric Oxide toxicity in CNS white matter: an in vitro study using rat optic nerve. Neuroscience. 109:2002;145-155.
12. Grady M.S., McLaughlin M.R., Christman C.W., Valadka A.B., Flinger C.L., Povlishock J.T. The use of antibodies targeted against neurofilament subunits for the detection of diffuse axonal injury in humans. J. Neuropathol. Exp. Neurol. 52:1993;143-152.
13. Griffiths I.R., Klugmann M., Anderson T., Yool D., Thomson C., Schwab M.H., Schneider A., Zimmerman F., McCulloch M., Nadon N., Nave K.-A. Axonal swellings and degeneration in mice lacking the major proteolipid of myelin. Science. 280:1998;1610-1613.
14. Hopkins J.K., Wang G.-J., Schmued L.C. Temporal progression of kainic acid induced neuronal and myelin degeneration in the rat forebrain. Brain Res. 864:2000;69-80.
15. Kanellopoulos G.K., Xu X.M., Hsu C.Y., Lu X., Sundt T.M., Kouchoukos N.T. White matter injury in spinal cord ischemia: protection by AMPA/kainate glutamate receptor antagonism. Stroke. 31:2000;1945-1952.
16. Lees K.R., Lavelle J.F., Cunha L., Diener H.C., Sanders E.A., Tack P., Wester P. Glycine antagonist (GV150526) in acute stroke: a multicentre, double-blind placebo-controlled phase II trial. Cerebrovasc. Dis. 11:2001;20-29.
17. Li S., Stys P.K. Mechanisms of ionotropic glutamate receptor-mediated excitotoxicity in isolated spinal cord white matter. J. Neurosci. 20:2000;1190-1198.
18. +-dependent glutamate transport. J. Neurosci. 19(RC16):1999;1-9.
19. Liu H., Giasson B.I., Mushynski W.E., Almazon G. AMPA receptor-mediated toxicity in oligodendrocyte progenitors involves free radical generation and activation of JNK, calpain and caspase 3. J. Neurochem. 82:2002;398-409.
20. Matute C. Characteristics of acute and chronic kainate excitotoxic damage to the optic nerve. Proc. Natl. Acad. Sci. 95:1998;10229-10234.
21. Matute C., Saanchez-Gomez M.V., Martinez-Millan L., Miledi R. Glutamate receptor-mediated toxicity in optic nerve oligodendrocytes. Proc. Natl. Acad. Sci. 94:1997;8830-8835.
22. McCracken E., Valeriani V., Simpson C., Jover T., McCulloch J., Dewar D. The lipid peroxidation by-product 4-hydroxynonenal is toxic to axons and oligodendrocytes. J. Cereb. Blood Flow Metab. 20:2000;1529-1536.
23. McCracken E., Dewar D., Hunter A.J. White matter damage following systemic injection of the mitochondrial inhibitor 3-nitropropionic acid in rat. Brain Res. 892:2001;329-335.
24. McCracken E., Fowler J.H., Dewar D., Morrison S., McCulloch J. Grey matter and white matter ischemic damage is reduced by the competitive AMPA receptor antagonist, SPD 502. J. Cereb. Blood Flow Metab. 22:2002;1090-1097.
25. McCulloch J. Excitatory amino acid antagonists and their potential for the treatment of ischemic brain damage in man. Br. J. Clin. Pharmacol. 34:1992;106-114.
26. McDonald J.W., Althomsons S.P., Hyrc K.L., Choi D.W., Goldberg M.P. Oligodendrocytes from forebrain are highly vulnerable to AMPA/kainate receptor-mediated excitotoxicity. Nat. Med. 4:1998;291-297.
27. Medana I.M., Day N.P., Hien T.T., Mai N.T.H., Bethell D., Phu N.H., Farrar J., Esiri M.M., White N.J., Turner G.D. Axonal injury in cerebral malaria. Am. J. Pathol. 160:2002;655-666.
28. Merrill J.E., Murphy S.P., Mitrovic B., Mackenzie-Graham A., Dopp J.C., Ding M., Griscavage J., Ignarro L.J., Lowenstein C.J. Inducible nitric oxide synthase and nitric oxide production by oligodendrocytes. J. Neurosci. Res. 48:1997;372-384.
29. Nielsen E.O., Varming T., Mathiesen C., Jensen L.F., Moller A., Gouliaev A.H., Watjen F., Drejer J. SPD 502: a water soluble and in vivo long-lasting AMPA antagonist with neuroprotective activity. J. Pharmacol. Exp. Ther. 289:1999;1492-1501.
30. Noda M., Nakanshi H., Nabekura J., Akaike N. AMPA-kainate subtypes of glutamate receptor in rat cerebral mircroglia. J. Neurosci. 20:2000;251-258.
31. Pantoni L., Garcia J.H., Gutierrez J.A. Cerebral white matter is highly vulnerable to ischemia. Stroke. 27:1996;1641-1647.
32. Patneau D.K., Wright P.W., Winters C., Mayer M.L., Gallo V. Glial cells of the oligodendrocyte lineage express both kainate- and AMPA-preferring subtypes of glutamate receptor. Neuron. 12:1994;357-371.
33. Paxinos G., Watson C. The Rat Brain in Stereotaxic Co-Ordinates. 1986;Academic Press, Sydney, Australia.
34. Pitt D., Werner P., Raine C.S. Glutamate excitotoxicity in a model of multiple sclerosis. Nat. Med. 6:2000;67-70.
35. Raja F., Sherriff F.E., Morris C.S., Bridges L.R., Esiri M.M. Cerebral white matter damage in HIV infection demonstrated using beta-amyloid precursor protein immunoreactivity. Acta Neuropathol. 93:1997;184-189.
36. Rosenberg L.J., Teng Y.D., Wrathall J.R. 2,3-dihydroxy-6-nitro- 7sulfamoyl-benzo(f) quinoxaline reduces glial loss and acute white matter pathology after experimental spinal cord contusion. J. Neurosci. 19:1998;464-475.
37. Saatman K.E., Graham D.I., McIntosh T.K. The neuronal cytoskeleton is at risk after mild and moderate brain injury. J. Neurotrauma. 15:1998;1047-1057.
38. Sanchez-Gomez M.A., Matute C. AMPA and kainate receptors each mediate excitotoxicity in oligodendroglial cultures. Neurobiol. Dis. 6:1999;475-485.
39. Simson E.L., Gold R.M., Standish L.J., Pellet P.L. Axon-sparing brain lesioning technique: the use of monosodium-L-glutamate and other amino acids. Science. 198:1977;515-517.
40. Smith K.J., Kapoor R., Hall S.M., Davie M. Electrically active axons degenerate when exposed to nitric oxide. Ann. Neurol. 49:2001;470-476.
41. Steinhauser S., Gallo V. News on glutamate receptors in glial cells. TINS. 19:1996;339-345.
42. Tekkok S.B., Goldberg M.P. AMPA/Kainate receptor activation mediated hypoxic oligodendrocyte death and axonal injury in cerebral white matter. J. Neurosci. 21:2001;4237-4248.
43. Touil T., Deloire-Grassin M.S., Vital C., Petry K.G., Brochet B. In vivo damage of CNS myelin and axons induced by peroxynitrite. NeuroReport. 12:2001;3637-3644.
44. Underhill S.M., Goldberg M.P. Glutamate-independent hypoxic injury of isolated axons from cultured cortical neurons. Soc. Neurosci. Abstr. 27:2002;869.2.
45. Underhill S.M., Goldberg M.P. Cell culture models of white matter vulnerability to excitotoxicity. Glia. (Supplement 1):2002;247.
46. Wrathall J.R., Choiniere D., Teng Y.D. Dose-dependent reduction of tissue loss and functional impairment after spinal cord trauma with the AMPA/kainate antagonist NBQX. J. Neurosci. 14:1994;6598-6607.
47. Wrathall J.R., Teng Y.D., Marriot R. Delayed antagonism of AMPA/kainate receptors reduces long-term functional deficits resulting from spinal cord trauma. Exp. Neurol. 145:1997;565-573.
48. Yaghmai A., Povlishock J. Traumatically induced reactive change as visualized through the use of monoclonal antibodies targeted to neurofilament subunits. J. Neuropathol. Exp. Neurol. 51:1992;158-176.
49. Yam P.S., Dewar D., McCulloch J. Axonal injury caused by focal cerebral ischemia in the rat. J. Neurotrauma. 15:1998;441-449.
50. Yam P.S., Dunn L.T., Graham D.I., Dewar D., McCulloch J. NMDA receptor blockade fails to alter axonal injury in focal cerebral ischemia. J. Cereb. Blood Flow Metab. 20:2000;772-779.
51. Yoshoika A., Hardy M., Younkin D.P., Grinspan J.B., Stern J.L., Pleasure D. α-amino-3-hydroxy-5-methyl-4-isoxazoleproprionate (AMPA) receptors mediate excitotoxicity in the oligodendroglial lineage. J. Neurochem. 64:1995;2442-2448.